Using Elevated Cholesterol Synthesis as a Prognostic Marker in Wilms' Tumor: A Bioinformatic Analysis

Area of Science:

• Pediatric Oncology
• Cancer Molecular Biology
• Immunology

Background:

• Wilms tumor is the most common pediatric renal malignancy.
• Elevated cholesterol synthesis is associated with poor prognosis in various cancers.
• The specific role of cholesterol biosynthesis in Wilms tumor remains unclear.

Purpose of the Study:

• To investigate the association between cholesterol synthesis and Wilms tumor prognosis.
• To explore the impact of cholesterol synthesis on the tumor microenvironment.
• To develop a predictive model for Wilms tumor patient outcomes.

Main Methods:

• Utilized RNA sequencing transcriptome data from the TARGET database for 130 Wilms tumor samples and 6 normal samples.
• Analyzed high-throughput sequencing data (FPKM).
• Constructed a prognosis model using differentially expressed cholesterol synthesis-related genes (DECSGs).

Main Results:

• Higher cholesterol synthesis activity correlated with worse overall survival (OS) in Wilms tumors (P < 0.05).
• Reduced cholesterol synthesis was associated with improved dendritic cell (DC) function and cytolytic activity (P < 0.05).
• DECSGs were significantly enriched in cell cycle and nuclear division pathways.

Conclusions:

• Increased cholesterol synthesis in Wilms tumors predicts poorer prognosis and diminished anti-tumor immunity.
• A novel prognostic model based on DECSGs accurately predicts patient OS.
• Further research is needed to elucidate the mechanisms linking cholesterol to Wilms tumor progression.